Antibiotics-Cell Wall Agents Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Penicillin G

A
  • Penicillins – usually IM, can be IV
  • Acid-labile (broken down in stomach) – inhibit PBPs and PDG cross-linking - bactericidal
  • Allergies, dose dependent neurotoxicity and seizures, Stevens Johnson syndrome
  • Gram + and some gram – cocci (Strep pneumonia, Staph, Neisseria, Clostridium, Treponema pallidum)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Penicillin V

A
  • Penicillins - oral
  • Acid stable – inhibit PBPs and PBG cross-linking - bactericidal
  • Allergies, Stevens Johnson syndrome
  • Gram + and some gram – cocci (Strep pneumonia, Staph, Neisseria, Clostridium, Treponema pallidum)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Oxacillin

Nafcillin

A

*B-lactamase resistant
Penicillinase-resistant
*Acid stable, food interferes with absorption, give parenterally - inhibit PBPs and PBG cross-linking - bactericidal
*Hepatitis at high doses
*Penicillinase-producing Staph and Strep (NOT FOR MRSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amoxicillin

Ampicillin

A
  • Extended spectrum
  • Destroyed by B-lactamases – acid stable, amoxicillin > ampicillin absorption - inhibit PBPs and PBG cross-linking - bactericidal
  • Non-lactamase gram- bacilli (E. coli, H. influenza, Salmonella, Shigella), prophylaxis against bacterial endocarditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Piperacillin

A
  • Extended spectrum – parenteral administration
  • Destroyed by B-lactamases - inhibit PBPs and PBG cross-linking - bactericidal
  • Serious systemic infections (Klebsiella and Pseudomonas) – combo with aminoglycoside to prevent resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ticarcillin

A
  • Extended spectrum – parenteral administration
  • Destroyed by B-lactamases - inhibit PBPs and PBG cross-linking - bactericidal
  • Anti-pseudomonal, rarely used alone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clavulanic acid
Sulbactam
Tazobactam

A
  • B-lactamase inhibitor
  • B-lactamase suicide inhibitors
  • Used in fixed concentrations with extended spectrum penicillins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cefazolin

A
  • Cephalosporin – 1st generation – oral, IV, IM
  • Bind to PBPs and inhibit cell wall synthesis – best acid stability
  • Allergy
  • Broadest spectrum against gram + cocci (surgical prophylaxis), gram – bacilli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cefuorxime

A
  • Cephalosporin – 2nd generation – oral, IV, IM
  • Bind to PBPs and inhibit cell wall synthesis
  • Allergy, Antabuse effect (sensitivity to alcohol)
  • Activity against anaerobes – diverticulitis, sinusitis, peritonitis, otitis media
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cefotaxime

A
  • Cephalosporin – 3rd generation – oral, IV, IM
  • Bind to PBPs and inhibit cell wall synthesis
  • Allergy, Antabuse effect (sensitivity to alcohol)
  • Anti-pseudomonal and pneumococcal, serious gram – infections (meningitis, pneumonia, gonorrhea) – children and infants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cefepime

A
  • Cephalosporin – 4th generation – oral, IV, IM
  • Bind to PBPs and inhibit cell wall synthesis
  • Allergy
  • Anti-pseudomonal, high resistance to B-lactamases (good for Enterobacter and penicillin resistant Strep)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Imipenem

A
  • Carbapenem – parenteral administration
  • Has B-lactam ring, binds more efficiently with PBPs, penetrate outer membrane of gram - bacteria
  • GI effects, super infections, neurtoxicity - Renal metabolism and inactivation (administered with cilastatin – inhibits dehydropeptidases)
  • Broadest activity of all B-lactam drugs, NOT for MRSA or VRE – 2nd line for serious nosocomial infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aztreonam

A
  • Monobactam – IM or IV use
  • Binds PBPs, relatively resistant to B-lactamases – drug penetrates inflamed CNS
  • No significant cross-reactivity with
  • Narrow spectrum, limited to gram- aerobes (Pseudomonas), not gram + or anaerobes – use for gram – UTIs, lower RTIs, and systemic infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bacitracin

A
  • Peptidoglycan synthesis inhibitor
  • Depletes lipid carrier for PDG synthesis – poorly absorbed
  • Severe nephrotoxicity
  • Topical only! – Narrow spectrum (gram +, Neisseria, T. pallidum) – skin and ophthalmologic infections (combination with polymyxin B)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cycloserine

A
  • Peptidoglycan synthesis inhibitor
  • Structural analog of D-alanine, blocks step 2 – good CNS penetration
  • VERY TOXIC – serious CNS effects, dose related, reversible
  • Broad spectrum – restricted second-line M. tuberculosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Daptomycin

A
  • Cell membrane agent – IV administration
  • Membrane depolarization, bactericidal
  • Myopathy
  • Narrow spectrum –serious gram+ infections, penicillin resistant S. pneumonia, VRE and MRSA
17
Q

Fosfomycin

A
  • Peptidoglycan synthesis inhibitor
  • Structural analog of PEP, blocks step 1 – well absorbed and distributed, rapid resistance
  • Few adverse effects (diarrhea, vaginitis)
  • Broad spectrum – single dose oral treatment of uncomplicated UTIs (E. coli and E. faecalis)
18
Q

Vancomycin

A
  • Peptidoglycan synthesis inhibitor – IV administration (SLOW), rarely oral (poor absorption, excellent distribution
  • Inhibits growth of strand by binding to D-ala dimer – blocks cross-linking by binding substrate – rapidly bactericidal for dividing cultures (except static in enterococci)
  • too fast IV administration – histamine release – HTN, tachycardia, flushing), ototoxicity, nephrotoxicity

VRE and VRSA resitant
*Narrow spectrum – gram + microbes (DRUG OF CHOICE FOR MRSA) – serious gram+ infections, penicillin resistant S. pneumonia, combination with aminoglycosides (synergistic)